NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,848,834 | -9.0% | 832,742 | +0.1% | 0.06% | -5.2% |
Q2 2023 | $40,482,687 | -13.9% | 831,950 | -1.8% | 0.06% | -17.1% |
Q1 2023 | $47,024,774 | +38.3% | 846,988 | +0.0% | 0.07% | +29.6% |
Q4 2022 | $34,012,863 | -4.7% | 846,723 | +4.0% | 0.05% | -8.5% |
Q3 2022 | $35,686,000 | +8.0% | 814,385 | -9.2% | 0.06% | +18.0% |
Q2 2022 | $33,054,000 | -14.8% | 896,514 | -4.3% | 0.05% | -2.0% |
Q1 2022 | $38,817,000 | -31.0% | 936,482 | +55.5% | 0.05% | -30.1% |
Q4 2021 | $56,239,000 | -2.5% | 602,196 | +16.4% | 0.07% | -18.0% |
Q3 2021 | $57,661,000 | -6.3% | 517,415 | -4.6% | 0.09% | +15.6% |
Q2 2021 | $61,561,000 | +169.9% | 542,243 | +141.3% | 0.08% | +156.7% |
Q1 2021 | $22,813,000 | -52.0% | 224,675 | -52.9% | 0.03% | -9.1% |
Q4 2020 | $47,514,000 | +121.1% | 477,432 | +57.3% | 0.03% | -2.9% |
Q3 2020 | $21,485,000 | +57.0% | 303,541 | +10.6% | 0.03% | +36.0% |
Q2 2020 | $13,688,000 | – | 274,532 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |